Please login to the form below

Not currently logged in
Email:
Password:

neurodegeneration

This page shows the latest neurodegeneration news and features for those working in and with pharma, biotech and healthcare.

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

Morning brief: New biotech launched, Merck and Moderna expand collaboration and more

Preclinical data suggest this could lead to treatments for diseases including lysosomal storage disorders, liver and muscle diseases, inflammatory disorders and neurodegeneration.

Latest news

More from news
Approximately 1 fully matching, plus 26 partially matching documents found.

Latest Intelligence

  • Holding on to hope for Alzheimer’s advances Holding on to hope for Alzheimer’s advances

    abnormalities including seizures, neurodegeneration, cognitive deficits and hypomyelination… it is completely unclear whether BACE could be targeted in a manner to affect amyloid processing in a therapeutic manner, without serious

  • Pharma deals in September 2015 Pharma deals in September 2015

    Gencia is also at the discovery phase in mitochondrial therapies in neurodegeneration, cardiovascular disease and other areas.

  • Pharma deals during February 2014 Pharma deals during February 2014

    adolescence, and ultimately neurodegeneration due to the formation of fatty yellow nodules (xanthomas) in the brain.

  • Interview: Mike Hutton, Lilly Interview: Mike Hutton, Lilly

    influence driving the neurodegeneration seen in the disease. ... of molecules throughout the cell – leading to neurodegeneration. “

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Healthcare Media Europe – HME Ltd

HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics